RS
CCCC icon

R Squared’s C4 Therapeutics CCCC Stock Holding History

R Squared’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,674
Closed -$26.1K – 516
2025
Q4 		$26.1K Sell
13,674
-4,206
-24% -$9.96K 0.01% 484
2025
Q3 		$39.7K Sell
17,880
-12,707
-42% -$30.5K 0.02% 506
2025
Q2 		$43.7K Buy
+30,587
New +$44.5K 0.02% 402
2025
Q1 		– Sell
-3,310
Closed -$11.9K – 506
2024
Q4 		$11.9K Buy
+3,310
New +$16.5K 0.01% 1090

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return